The global nucleic acid isolation and purification market size is expected to value USD 9.8 billion by 2028, expanding at a compound annual growth rate (CAGR) of 11.4% from 2021 to 2028. The market growth is primarily attributed to the rising research and development (R&D) activities, advancements made in personalized medicines and medical diagnostics, and the increasing adoption of automation in emerging countries. The emergence of sophisticated diagnostics and customized therapy, mainly for the treatment of infectious diseases, genetic disorders, and cancer, coupled with genetic advancements are all widening the market growth opportunities.
As molecular biology is making major strides in disease diagnosis, nucleic acids are now used in a wide range of medical fields, including gene therapy and precision medicine, in addition to protein synthesis and genetic information storage. Therefore, it is anticipated that rising R&D efforts across the molecular biology industry and booming demand for cutting-edge methods such as next-generation sequencing (NGS) will lead to profitable market growth prospects.
Since the COVID-19 outbreak, the European Medicine Agency in the U.K. has started employing nucleic acid testing to identify coronavirus among patients. New coronavirus variations are predicted to present enormous sales prospects in the U.K. market since nucleic acid isolation and purification kits are essential for these diagnostic procedures. Additionally, the growing use of sequencing techniques to identify and diagnose diseases like cancer, influenza, HIV-AIDS, and others as well as the increasing investment by governments and private organizations in nucleic-based clinical diagnostics are anticipated to support the sales of nucleic acid isolation and purification in the U.K.
Novel molecular diagnostics, such as nucleic acid hybridization and nucleic acid sequence analysis, have become vital in a variety of medical sectors as a result of the rapid growth of molecular biotechnology. Therefore, the market's top competitors are concentrating on forming strategic partnerships to improve their product portfolio. For example in 2020, Zymo Research announced a collaboration with Tecan, a company that sells lab equipment and solutions, to develop ready-to-use devices that will simplify the extraction of DNA and RNA for nucleic acid hybridization. Such product developments are anticipated to aid in market expansion.
Nucleic Acid Isolation And Purification Market Report Key Takeaways
- Formalin-Fixed Paraffin-Embedded (FFPE) trials are used to identify molecular links of carcinogenesis. They often mandate labor-intensive nucleic acid purification and can damage the samples. To come around this issue, companies are launching innovative kits for effective nucleic acids recovery
- In March 2021, the Ionic FFPE Complete Purification Kit was launched by Purigen Biosystems, Inc. to recover DNA/RNA from FFPE tissue specimens in a single procedure. When compared to the manual column or bead-based approaches, the Iconic FFPE kit helps to streamline the results by cutting down on hands-on time by about 75%. Similar other developments are fast-tracking market expansion
- Based on products, the kits and reagents segment captured the largest market share of 76.0% in 2020, owing to its wide-scale application in RNA and DNA isolation, and the instruments product segment is estimated to grow at the fasted rate of 12.6% during the forecast period
- The RNA isolation and purification type segment accounted for the highest revenue share of 53.6% in 2020 as a result of its rising use in COVID-19 diagnostics
- Geographically, the Asia Pacific region is set to exhibit the highest CAGR since China is projected to transpire as a highly remunerative market between 2022 and 2029. China has a very high prevalence of chronic ailments.
- For instance, the Precision Cancer Medicine estimates that there were approximately 4.6 million new instances of cancer in China by 2020, representing an incidence rate of 174 per 100,000 people
Nucleic Acid Isolation And Purification Market Segments
- Nucleic Acid Isolation & Purification Product Outlook (Revenue, USD Million, 2017 - 2028)
- Kits & Reagents
- Instruments
- Nucleic Acid Isolation & Purification Type Outlook (Revenue, USD Million, 2017 - 2028)
- DNA Isolation & Purification (I&P)
- Genomic DNA I&P
- Plasmid DNA I&P
- Viral DNA I&P
- Other
- RNA Isolation & Purification
- miRNA Isolation & Purification
- mRNA Isolation & Purification
- Total RNA Isolation & Purification
- Other
- Nucleic Acid Isolation & Purification Method Outlook (Revenue, USD Million, 2017 - 2028)
- Column-based
- Magnetic Beads
- Reagent-based
- Others
- Nucleic Acid Isolation & Purification Application Outlook (Revenue, USD Million, 2017 - 2028)
- Precision Medicine
- Diagnostics
- Drug Discovery & Development
- Agriculture and Animal Research
- Other Applications
- Nucleic Acid Isolation & Purification End-use Outlook (Revenue, USD Million, 2017 - 2028)
- Academic Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Hospitals and Diagnostic Centers
- Other End-use
- Nucleic Acid Isolation & Purification Regional Outlook (Revenue, USD Million, 2017 - 2028)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa (MEA)
- List of Key Players of Nucleic Acid Isolation And Purification Market
- QIAGEN
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Danaher
- F. Hoffmann-La Roche AG
- Merck KGaA
- Agilent Technologies
- Bio-Rad Laboratories, Inc.
- Takara Bio, Inc.
- Promega Corporation
- New England Biolabs
- LGC Limited
- Abcam plc
- Norgen Biotek Corp
- AutoGen, Inc.
- Biogenuix
- PCR Biosystems, Inc.
- MagGenome
- Apical Scientific Sdn. Bhd
- MACHEREY-NAGEL GmbH & Co. KG
